Publications by authors named "Marco A Colleoni"

Claim this Profile
I
Invasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research group.
Giovanni Corso, Sherry Shen, Carmen Criscitiello, Rita Mukhtar, Lauren Gamble, Marco Angelo Colleoni

Cancer Treat Rev· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastasis-directed thermal ablation in patients with metastatic breast cancer and visceral oligoprogression or oligopersistence: a cohort study.
Nadia Bianco, Carmine Valenza, Monica Milano, Roberta Multinu, Elena Battaiotto, Marco A Colleoni

Breast· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metaplastic breast cancer: Prognostic and therapeutic considerations.
Giovanni Corso, Samuele Frassoni, Antonia Girardi, Elisa De Camilli, Emilia Montagna, Marco Angelo Colleoni

J Surg Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer.
Fabio Zugni, Francesca Ruju, Paola Pricolo, Sarah Alessi, Monica Iorfida, Marco Angelo Colleoni

PLoS One· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer.
Luca Magnani, Gianmaria Frigè, Raffaella Maria Gadaleta, Giacomo Corleone, Sonia Fabris, Marco Angelo Colleoni

Nat Genet· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer.
Luca Magnani, Gianmaria Frige, Raffaella Maria Gadaleta, Giacomo Corleone, Sonia Fabris, Marco Angelo Colleoni

Nat Genet· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Oncoplastic Breast-Conserving Surgery for Tumors Larger than 2 Centimeters: Is it Oncologically Safe? A Matched-Cohort Analysis.
Francesca De Lorenzi, Pietro Loschi, Vincenzo Bagnardi, Nicole Rotmensz, Gabriel Hubner, Marco Angelo Colleoni

Ann Surg Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncoplastic Breast-Conserving Surgery for Tumors Larger than 2 Centimeters: Is it Oncologically Safe? A Matched-Cohort Analysis.
Francesca De Lorenzi, Pietro Loschi, Vincenzo Bagnardi, Nicole Rotmensz, Gabriel Hubner, Marco Angelo Colleoni

Ann Surg Oncol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting bone metastatic cancer: Role of the mTOR pathway.
Francesco Bertoldo, Franco Silvestris, Toni Ibrahim, Francesco Cognetti, Daniele Generali, Marco Angelo Colleoni

Biochim Biophys Acta· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant therapy in locally advanced breast cancer: 99mTc-MIBI mammoscintigraphy is not a reliable technique to predict therapy response.
Laura Lavinia Travaini, Silvia Melania Baio, Marta Cremonesi, Concetta De Cicco, Mahila Ferrari, Marco Angelo Colleoni

Breast· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis